AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2010
May 21, 2010
34301_dirs_2010-05-21_2a93cf21-09af-49b1-80b4-3037a34c9889.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-05-21
Reporting Person: Saad Mark E (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-21 | Common Stock | P | 900 | $4.28 | Acquired | 77400 | Direct |
| 2010-05-21 | Common Stock | P | 4100 | $4.29 | Acquired | 81500 | Direct |
| 2010-05-21 | Common Stock | P | 1000 | $4.3 | Acquired | 82500 | Direct |
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 13